Results 261 to 270 of about 643,840 (294)

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

Lancet, The, 2023
Sara Lonardi, Kohei Shitara, Josep Tabernero Caturla   +2 more
exaly  

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Lancet, The, 2021
Cristina Arriens, Dawn J Caster, Juanita Romero-Díaz   +2 more
exaly  

Placebo responses in animals

Pain, 2012
openaire   +3 more sources

The placebo response in medicine: minimize, maximize or personalize?

Nature Reviews Drug Discovery, 2013
Paul Enck, Ulrike Bingel, Manfred Schedlowski   +2 more
exaly  

Placebo Response and Placebo Effect

Neurologic Clinics
Fabrizio Benedetti, Aziz Shaibani
openaire   +1 more source

IS HOMOEOPATHY A PLACEBO RESPONSE? CONTROLLED TRIAL OF HOMOEOPATHIC POTENCY, WITH POLLEN IN HAYFEVER AS MODEL

Lancet, The, 1986
Charles P Mcsharry
exaly  

Placebo effects and their determinants in gastrointestinal disorders

Nature Reviews Gastroenterology and Hepatology, 2015
Sigrid Elsenbruch, Paul Enck
exaly  

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Lancet, The, 2019
Paul Emery, William F C Rigby, Yoshiya Tanaka   +2 more
exaly  

Placebo Response

2013
openaire   +1 more source

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2018
Gerd R Burmester, Joel M Kremer, Filip E Van Den Bosch   +2 more
exaly